Advertisement

Epidemiology-Based Mortality Score is Associated with Long-Term Mortality after Status Epilepticus

  • Harald Settergren Møller
  • Emmely Rodin
  • Preben Aukland
  • Martin Lando
  • Elsebeth Bruun Christiansen
  • Christoph Patrick BeierEmail author
Original Research
  • 34 Downloads

Abstract

Background/Objective

Status epilepticus (SE) is a life-threatening condition with a high long-term mortality. The correct prediction of the individual patient’s outcome is crucial for stratifying treatment. Status epilepticus severity score (STESS) and the epidemiology-based mortality score (EMSE) are well established for predicting in-hospital mortality; however, scores indicating long-term mortality are lacking. We here studied the association of both scores with mortality after discharge and long-term mortality.

Methods

In this retrospective cohort study of adult patients with incident, non-anoxic, first-time SE (from 01/2008 to 12/2014), STESS, EMSE-EACE (etiology-age-comorbidity-EEG), demographic data, modified Rankin Scale at discharge, treatment, date of diagnosis, and date of death were determined based on electronic patients charts.

Results

A total of 129 patients with a median follow-up of 24.8 months were included. We found no significant difference between STESS and EMSE-EACE in predicting in-hospital and 3 months mortality. At end-of-study, EMSE-EACE with a cutoff of ≥ 64 showed the best association with overall survival. At last follow-up, only 15.7% (8 out of 51) of the patients with EMSE ≥ 64 were alive as compared to 32.4% (24 out of 74) of the patients with STESS ≥ 3. Median survival of patients with EMSE-EACE ≥ 64 and EMSE-EACE < 64 was 6.4 months (95% confidence interval (CI) 2.3–15.3 months) and 35.8 months (CI 32.8–37.9 months), respectively. In the subgroup of patients that were discharged alive from the hospital, EMSE-EACE was highly significantly associated with mortality (p < 0.001) after discharge. In the same patients, STESS with a cutoff of STESS ≥ 3 reached only borderline significance (p = 0.04), STESS with a cutoff of STESS ≥ 4 did not reach statistical significance (p = 0.23). Exploratory analyses of different EMSE components unveiled a strong association of etiology with in-house mortality but not with long-term survival. In patients discharged alive from the hospital, only comorbidity and age remained significantly associated with long-term mortality.

Conclusions

In our cohort, EMSE-EACE was significantly associated with long-term survival after discharge.

Keywords

Status epilepticus Long-term mortality STESS EMSE 

Notes

Author Contributions

HSM assessed EMSE in the cohort, statistical analyses, wrote, and approved the manuscript. ER analyzed patients from 2014 and approved the manuscript. PA analyzed patients diagnosed from 2008 to 2013 and approved the manuscript. ML analyzed patients diagnosed from 2008 to 2013 and approved the manuscript. EBC helped with the analysis of patients diagnosed from 2008 to 2013 and approved the manuscript. CPB designed the study, statistical analyses, wrote, and approved the manuscript.

Financial Support

This study was supported by a Grant of the Region of Southern Denmark to CPB (17/18517).

Compliance with Ethical Standards

Conflicts of Interest

Harald S. Møller received research support from UCB. Emmely Rodin, Preben Aukland Martin Lando, and Elsebeth B. Christiansen report no disclosures. Christoph P. Beier served as an advisory board member for UCB and EISAI, received speakers honoraries from UCB, EISAI, and the Danish Epilepsy Association, and research support from UCB, EISAI, Novartis, and Pfizer.

Ethical Approval

The study was evaluated and approved by the Ethic Committee of the Region of Southern Denmark.

Supplementary material

12028_2018_663_MOESM1_ESM.docx (33 kb)
Supplementary material 1 (DOCX 32 kb)

References

  1. 1.
    Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3–23.PubMedCrossRefGoogle Scholar
  2. 2.
    Chin RF, Neville BG, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol. 2004;11(12):800–10.PubMedCrossRefGoogle Scholar
  3. 3.
    Sutter R, Marsch S, Fuhr P, Kaplan PW, Ruegg S. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology. 2014;82(8):656–64.PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Marchi NA, Novy J, Faouzi M, et al. Status epilepticus: impact of therapeutic coma on outcome. Crit Care Med. 2015;43(5):1003–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Rossetti AO, Logroscino G, Milligan TA, et al. Status epilepticus severity score (STESS): a tool to orient early treatment strategy. J Neurol. 2008;255(10):1561–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Rossetti AO, Logroscino G, Bromfield EB. A clinical score for prognosis of status epilepticus in adults. Neurology. 2006;66(11):1736–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Sutter R, Kaplan PW, Ruegg S. Independent external validation of the status epilepticus severity score. Crit Care Med. 2013;41(12):e475–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Aukland P, Lando M, Vilholm O, Christiansen EB, Beier CP. Predictive value of the status epilepticus severity score (STESS) and its components for long-term survival. BMC Neurol. 2016;16(1):213.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Reindl C, Knappe RU, Sprügel MI, et al. Comparison of scoring tools for the prediction of in-hospital mortality in status epilepticus. Seizure. 2018;56(1):5.Google Scholar
  10. 10.
    Leitinger M, Holler Y, Kalss G, et al. Epidemiology-based mortality score in status epilepticus (EMSE). Neurocrit Care. 2015;22(2):273–82.PubMedCrossRefGoogle Scholar
  11. 11.
    Yechoor N, Adeli A, Hafeez S. External validation of the epidemiology-based mortality score in status epilepticus in an American intensive care population. Epilepsy Res. 2018;148:32–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Ulvin LB, Heuser K, Olsen KB, Tauboll E. Factors associated with refractoriness and outcome in an adult status epilepticus cohort. Seizure. 2018;61:111–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Giovannini G, Monti G, Tondelli M, et al. Mortality, morbidity and refractoriness prediction in status epilepticus: comparison of STESS and EMSE scores. Seizure. 2017;46:31–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Gonzalez-Cuevas M, Santamarina E, Toledo M, et al. A new clinical score for the prognosis of status epilepticus in adults. Eur J Neurol. 2016;23(10):1534–40.PubMedCrossRefGoogle Scholar
  15. 15.
    Gao Q, Ou-Yang TP, Sun XL, et al. Prediction of functional outcome in patients with convulsive status epilepticus: the END-IT score. Crit Care. 2016;20:46.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Alvarez V, Januel JM, Burnand B, Rossetti AO. Role of comorbidities in outcome prediction after status epilepticus. Epilepsia. 2012;53(5):e89–92.PubMedCrossRefGoogle Scholar
  17. 17.
    Kang BS, Kim DW, Kim KK, et al. Prediction of mortality and functional outcome from status epilepticus and independent external validation of STESS and EMSE scores. Crit Care. 2016;20(1):25.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Santamarina E, Gonzalez-Cuevas GM, Sanchez A, et al. Prognosis of status epilepticus in patients requiring intravenous anesthetic drugs (a single center experience). Seizure. 2017;45:74–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Reindl C, Knappe RU, Sprugel MI, et al. Comparison of scoring tools for the prediction of in-hospital mortality in status epilepticus. Seizure. 2018;56:92–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Rodriguez DR, Matamoros CS, Sam K, et al. Evaluation of STESS, mRSTESS, and EMSE to predict high disability and mortality at hospital discharge in ecuadorian patients with status epilepticus. Neurocrit Care. 2018;29:413–8.CrossRefGoogle Scholar
  21. 21.
    Zhang Y, Chen D, Xu D, Tan G, Liu L. Clinical utility of EMSE and STESS in predicting hospital mortality for status epilepticus. Seizure. 2018;60:23–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Logroscino G, Hesdorffer DC, Cascino GD, et al. Long-term mortality after a first episode of status epilepticus. Neurology. 2002;58(4):537–41.PubMedCrossRefGoogle Scholar
  23. 23.
    Ristic AJ, Sokic DV, Trajkovic G, et al. Long-term survival in patients with status epilepticus: a tertiary referral center study. Epilepsia. 2010;51(1):57–61.PubMedCrossRefGoogle Scholar
  24. 24.
    Kantanen AM, Reinikainen M, Parviainen I, Kalviainen R. Long-term outcome of refractory status epilepticus in adults: a retrospective population-based study. Epilepsy Res. 2017;133:13–21.PubMedCrossRefGoogle Scholar
  25. 25.
    Sculier C, Gainza-Lein M, Sanchez Fernandez I, Loddenkemper T. Long-term outcomes of status epilepticus: a critical assessment. Epilepsia. 2018;59:155–69.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Rodin E, Krogstad MH, Aukland P, et al. High long-term mortality after incident status epilepticus in adults: results from a population-based study. Epilepsia. 2018.  https://doi.org/10.1111/epi.14602.PubMedCrossRefGoogle Scholar
  27. 27.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefGoogle Scholar
  28. 28.
    Kortland L-M, Alfter A, Bähr O, et al. Costs and cost-driving factors for acute treatment of adults with status epilepticus: a multicenter cohort study from Germany. Epilepsia. 2016;57(12):2056–66.PubMedCrossRefGoogle Scholar
  29. 29.
    Holtkamp M, Othman J, Buchheim K, Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry. 2005;76(4):534–9.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Kantanen AM, Kalviainen R, Parviainen I, et al. Predictors of hospital and one-year mortality in intensive care patients with refractory status epilepticus: a population-based study. Crit Care. 2017;21(1):71.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Guidelines for Epidemiologic Studies on Epilepsy. Commission on epidemiology and prognosis, international league against epilepsy. Epilepsia. 1993;34(4):592–6.CrossRefGoogle Scholar
  32. 32.
    Sutter R, Dittrich T, Semmlack S, et al. Acute systemic complications of convulsive status epilepticus-a systematic review. Crit Care Med. 2018;46(1):138–45.PubMedCrossRefGoogle Scholar
  33. 33.
    Ciurans J, Grau-Lopez L, Jimenez M, et al. Refractory status epilepticus: impact of baseline comorbidity and usefulness of STESS and EMSE scoring systems in predicting mortality and functional outcome. Seizure. 2018;56:98–103.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society 2019

Authors and Affiliations

  1. 1.Department of NeurologyUniversity Hospital of OdenseOdense CDenmark
  2. 2.Department of NeurologyDistrict Hospital KoldingKoldingDenmark
  3. 3.Department of Clinical ResearchUniversity of Southern DenmarkOdenseDenmark

Personalised recommendations